| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 13.993 | 265.569 | 405.255 | 384.024 |
| Total Income - EUR | - | - | - | - | - | - | 13.993 | 265.569 | 405.255 | 384.571 |
| Total Expenses - EUR | - | - | - | - | - | - | 11.875 | 222.950 | 338.635 | 369.563 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.119 | 42.619 | 66.620 | 15.008 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.982 | 39.963 | 62.649 | 12.727 |
| Employees | - | - | - | - | - | - | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Iclorenix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 2.814 | 1.983 | 7.247 |
| Current Assets | - | - | - | - | - | - | 6.620 | 53.697 | 50.474 | 59.113 |
| Inventories | - | - | - | - | - | - | 3.619 | 9.848 | 12.269 | 38.413 |
| Receivables | - | - | - | - | - | - | 2.103 | 24.299 | 18.181 | 13.595 |
| Cash | - | - | - | - | - | - | 899 | 19.549 | 20.025 | 7.105 |
| Shareholders Funds | - | - | - | - | - | - | 2.022 | 41.991 | 29.736 | 41.040 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 4.598 | 14.519 | 22.722 | 25.319 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4687 - 4687" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Iclorenix S.r.l.